Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Clinical trial NCT05588323 · RECRUITING

Trial details

NCT number: NCT05588323
Sponsor: Shionogi
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Opioid-Induced Constipation (OIC)

Start date: 2023-01-04
Primary completion: 2028-06-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.